Schnack Tine H, Høgdall Estrid, Nedergaard Lotte, Høgdall Claus
*Gynecological Clinic, University Hospital of Copenhagen, København Ø; †Department of Pathology, University Hospital Herlev, Herlev; and ‡Department of Pathology, University Hospital of Copenhagen, København Ø, Denmark.
Int J Gynecol Cancer. 2016 Jan;26(1):82-90. doi: 10.1097/IGC.0000000000000585.
To compare clinical demographic and prognostic factors as well as overall survival in a nationwide cohort of patients diagnosed with ovarian clear cell carcinoma (oCCC) and high grade ovarian serous adenocarcinoma (oSAC) during 2005 to 2013.
Population-based prospectively collected data on oCCC (n = 179) and oSAC (n = 2363) cases were obtained from the Danish Gynecological Cancer Database. χ, Fischer or Wilcoxon-Mann-Whitney, multivariate logistic regression, univariate Kaplan-Meier, and multivariate Cox regression tests were used. Statistical tests were 2-sided. P values less than 0.05 were considered statistically significant.
The oCCC cases were significantly younger than oSAC cases. An inverse association between ever smoking and oCCC as compared to oSAC was observed and a significantly higher proportion of oCCC was found to be nulliparous (odds ratio, 0.62; 95% confidence interval, 0.37-0.92).Although more oSAC than oCCC cases diagnosed in stage III or IV were referred to neoadjuvant chemotherapy, a higher proportion of oCCC achieved complete cytoreduction at primary debulking surgery and/or had lymphadenectomy performed; overall survival were poorer among oCCC than oSAC cases in analyses restricted to stages III and IV (odds ratio, 1.87; 95% confidence interval, 1.35-2.61), whereas no difference between early stage oCCC and oSAC was observed.
The study confirms that demographic features and risk factors differ between oCCC and oSAC cases. Furthermore, our findings confirm that advanced stages of oCCC have a poorer prognosis compared with oSAC probably because of the resistance toward adjuvant chemotherapy. The observed differences highlight the need for subtype-specific research and individualized treatment within ovarian cancer.
比较2005年至2013年期间在全国范围内诊断为卵巢透明细胞癌(oCCC)和高级别卵巢浆液性腺癌(oSAC)的患者队列的临床人口统计学和预后因素以及总生存期。
基于人群前瞻性收集的oCCC(n = 179)和oSAC(n = 2363)病例的数据来自丹麦妇科癌症数据库。使用χ²检验、费舍尔检验或威尔科克森-曼-惠特尼检验、多因素逻辑回归、单因素卡普兰-迈耶检验和多因素考克斯回归检验。统计检验为双侧检验。P值小于0.05被认为具有统计学意义。
oCCC病例比oSAC病例明显年轻。与oSAC相比,观察到曾经吸烟与oCCC之间存在负相关,并且发现oCCC未生育的比例明显更高(比值比,0.62;95%置信区间,0.37 - 0.92)。虽然诊断为III期或IV期的oSAC病例比oCCC病例更多接受新辅助化疗,但oCCC在初次肿瘤细胞减灭术时实现完全肿瘤细胞减灭和/或进行淋巴结清扫的比例更高;在仅限于III期和IV期病例的分析中,oCCC的总生存期比oSAC病例差(比值比,1.87;95%置信区间,1.35 - 2.61),而早期oCCC和oSAC之间未观察到差异。
该研究证实oCCC和oSAC病例的人口统计学特征和危险因素不同。此外,我们的研究结果证实,oCCC晚期与oSAC相比预后较差,可能是因为对辅助化疗耐药。观察到的差异凸显了卵巢癌亚型特异性研究和个体化治疗的必要性。